Anxiety Clinical Trials in Philadelphia, PA

25 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety	Phase 3	Otsuka Pharmaceutical Development & Commercialization, Inc.	<1 mi
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device	—	Gaize	<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia	Phase 2	Syndeio Biosciences, Inc	<1 mi
ACT With CF Self-Help Toolkit	N/A	Thomas Jefferson University	<1 mi
Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities	N/A	Montclair State University	<1 mi
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos	N/A	Drexel University	<1 mi
Evaluation of the PACE/PACENET BHL Clinical Program	—	University of Pennsylvania	<1 mi
SEEG-Guided DBS for OCD	N/A	Casey H. Halpern, M.D.	<1 mi
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors	Phase 4	Memorial Sloan Kettering Cancer Center	<1 mi
Postpartum Care in the NICU (PeliCaN) Transitions	N/A	University of Pennsylvania	<1 mi
AI-Based Fidelity Feedback to Enhance CBT	N/A	University of Pennsylvania	<1 mi
Foundational Programs to Combat Clinician Stress	N/A	Lancaster General Hospital	<1 mi
Decoding and Modulating Affective Brain States	N/A	University of Pennsylvania	<1 mi
Telehealth Collaborative Care Model (CoCM) in Lung Cancer	N/A	Abramson Cancer Center at Penn Medicine	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome	N/A	The Cooper Health System	3 mi
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Phase 2	VistaGen Therapeutics, Inc.	12 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	12 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	12 mi
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments	—	Neuronetics	19 mi
Retrospective Analyses of TrakStar Database	—	Neuronetics	19 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	24 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)	Phase 3	Definium Therapeutics US, Inc.	38 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder	Phase 3	Vanda Pharmaceuticals	38 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.